Literature DB >> 15800662

Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model.

K Miwa1, H Nakashima, M Aoki, T Miyake, T Kawasaki, M Iwai, M Oishi, K Kataoka, S Ohgi, T Ogihara, Y Kaneda, R Morishita.   

Abstract

The pathophysiology of abdominal aortic aneurysms (AAA) is considered to be complicated. As matrix degradation contributes to the progression of AAA, the destruction and degradation of elastin fibers caused by an increase in matrix metalloproteinases (MMPs) plays a pivotal role in the development of AAA. Although ets, an essential transcription factor for angiogenesis, regulates MMPs, the role of ets in the development of AAA has not yet been clarified. Thus, we evaluated the role of ets in a rat AAA model using a decoy strategy. Transfection of ODN into AAA was performed by transient aortic perfusion of elastase and by wrapping the AAA in a delivery sheet containing decoy ODN. The inhibitory effect of ets decoy ODN on ets binding activity was confirmed by gel mobility shift assay. MMPs expression was decreased in the aorta transfected with ets decoy ODN as compared to scrambled decoy ODN. Also, ultrasound study demonstrated that elastase-induced aneurismal dilation was significantly suppressed by transfection of ets decoy ODN at 4 weeks after treatment as compared to scrambled decoy ODN. Moreover, the destruction of elastin fibers was inhibited in the aorta transfected with ets decoy ODN, accompanied by a reduction of MMPs expression. An inhibitory effect of decoy ODN on MMP expression was confirmed by ex vivo experiments showing that transfection of decoy ODN into an organ culture of human aorta resulted in significant inhibition of the secretion of both MMP-1 and MMP-9. Here, we demonstrated that ets may play a pivotal role in the progression of AAA through the activation of MMPs in a rat model. Ets might be a potential target to develop pharmacotherapy/gene therapy to treat AAA through the inhibition of MMPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800662     DOI: 10.1038/sj.gt.3302496

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  14 in total

1.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Yanwen Qin; Xu Cao; Jun Guo; Yaozhong Zhang; Lili Pan; Hongjia Zhang; Huihua Li; Chaoshu Tang; Jie Du; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

Review 3.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.

Authors:  Jeffrey A Jones; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-09-02       Impact factor: 1.934

4.  Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm.

Authors:  Jeffrey A Jones; John R Barbour; Robert E Stroud; Shenikqua Bouges; Shelly L Stephens; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-04-23       Impact factor: 1.934

5.  The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis.

Authors:  Kyung-Hyun Kim; Ji-Hyun Park; Woo-Ram Lee; Jae-Shin Park; Hyun-Chul Kim; Kwan-Kyu Park
Journal:  J Mol Med (Berl)       Date:  2012-11-01       Impact factor: 4.599

6.  Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.

Authors:  Jiusong Sun; Galina K Sukhova; Min Yang; Paul J Wolters; Lindsey A MacFarlane; Peter Libby; Chongxiu Sun; Yadong Zhang; Jian Liu; Terri L Ennis; Rebecca Knispel; Wanfen Xiong; Robert W Thompson; B Timothy Baxter; Guo-Ping Shi
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms.

Authors:  Jennifer Nischan; Zoran Gatalica; Mindee Curtis; Guy M Lenk; Gerard Tromp; Helena Kuivaniemi
Journal:  Circ Cardiovasc Genet       Date:  2009-10-19

8.  Transcriptional (ChIP-Chip) Analysis of ELF1, ETS2, RUNX1 and STAT5 in Human Abdominal Aortic Aneurysm.

Authors:  Matthew C Pahl; Robert Erdman; Helena Kuivaniemi; John H Lillvis; James R Elmore; Gerard Tromp
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

9.  Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm.

Authors:  Masaki Sano; Takeshi Sasaki; Satoshi Hirakawa; Junichi Sakabe; Mikako Ogawa; Satoshi Baba; Nobuhiro Zaima; Hiroki Tanaka; Kazunori Inuzuka; Naoto Yamamoto; Mitsutoshi Setou; Kohji Sato; Hiroyuki Konno; Naoki Unno
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.

Authors:  Yasunori Iida; Baohui Xu; Geoffrey M Schultz; Vinca Chow; Julie J White; Shola Sulaimon; Ayala Hezi-Yamit; Susan Rea Peterson; Ronald L Dalman
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.